KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Astrana Health (ASTH) over the last 5 years, with Q3 2025 value amounting to $30.1 million.

  • Astrana Health's Accumulated Expenses rose 7200.82% to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.1 million, marking a year-over-year increase of 7200.82%. This contributed to the annual value of $22.4 million for FY2024, which is 1149.87% up from last year.
  • Astrana Health's Accumulated Expenses amounted to $30.1 million in Q3 2025, which was up 7200.82% from $20.2 million recorded in Q2 2025.
  • Astrana Health's 5-year Accumulated Expenses high stood at $30.1 million for Q3 2025, and its period low was $13.8 million during Q1 2025.
  • Its 3-year average for Accumulated Expenses is $20.0 million, with a median of $20.1 million in 2023.
  • Per our database at Business Quant, Astrana Health's Accumulated Expenses surged by 1149.87% in 2024 and then surged by 7200.82% in 2025.
  • Over the past 3 years, Astrana Health's Accumulated Expenses (Quarter) stood at $20.1 million in 2023, then rose by 11.5% to $22.4 million in 2024, then skyrocketed by 34.31% to $30.1 million in 2025.
  • Its last three reported values are $30.1 million in Q3 2025, $20.2 million for Q2 2025, and $13.8 million during Q1 2025.